Nielsen, S. R., Strøbech, J. E., Horton, E. R., Jackstadt, R., Laitala, A., Bravo, M. C., . . . Erler, J. T. (2021). Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nature Portfolio.
Chicago Style (17th ed.) CitationNielsen, Sebastian R., et al. Suppression of Tumor-associated Neutrophils by Lorlatinib Attenuates Pancreatic Cancer Growth and Improves Treatment with Immune Checkpoint Blockade. Nature Portfolio, 2021.
MLA (8th ed.) CitationNielsen, Sebastian R., et al. Suppression of Tumor-associated Neutrophils by Lorlatinib Attenuates Pancreatic Cancer Growth and Improves Treatment with Immune Checkpoint Blockade. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.